{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to assess demographic differences in prevalence, risk profile, diagnostic tests and follow up pattern of myocardial infarction in young adults

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{--
--}} {{--
--}} {{--

--}} @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{-- @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif
--}} {{--

--}}
  1. What is the prevalence of myocardial infarction (MI) in young adults (age <50 years), as observed in your practice? *

  2. What is the prevalence of myocardial infarction (MI) in very young adults (age <30 years), as observed in your practice? *

  3. What percentage of young adults presenting with MI undergo primary Percutaneous coronary intervention (PCI)? *

  4. What percentage of young adults presenting with MI have multiple vessel disease (MVD)? *

  5. What are the most common underlying aetiologies observed in young adults presenting with MI? *
  6. What are the most common underlying aetiologies observed in very young adults (age<30 years) presenting with MI? *
  7. What percentage of young adults presenting with MI have family history of CAD? *

  8. What percentage of young adults presenting with MI have familial hypercholesterolemia? *

  9. What percentage of young adults presenting with MI have history of Diabetes (Type 2 diabetes)? *

  10. What percentage of young adults presenting with MI have history of Dyslipidaemia? *

  11. What percentage of young adults presenting with MI have history of hypertriglyceridemia? *

  12. What percentage of young adults presenting with MI have history of Hypertension? *

  13. What percentage of young adults presenting with MI have obesity? *

  14. What percentage of young adults presenting with MI have centripetal obesity? *

  15. What percentage of patients have multiple cardiovascular risk factors (either hypertension, diabetes, dyslipidaemia, obesity or other) *

  16. Which among the below is the most common presentation in clinical practice *

  17. What is the most common risk factor in obese patients *

  18. What are the lifestyle risk factors observed in young adults presenting with MI, as observed in your practice? *
  19. In a young adult presenting with MI, what are the preferred investigations conducted before undergoing PCI? *
  20. Is there a difference in investigations conducted in young adults and elderly patients presenting with MI? *
  21. Does every patient presenting MI undergo ECHO in your practice? *

  22. In a young adult presenting with MI, what are the preferred investigations conducted before discharge? *
  23. Lipid profile is investigated in what percentage of patients? *

  24. What is the most common presentation in patients with dyslipidaemia? *
  25. Glycaemic profile (HbA1c / FBG / PPBG) is investigated in what percentage of patients? *

  26. Renal function is evaluated in what percentage of patients? *

  27. What is the preferred method of evaluation for renal function? *
  28. Hypertension is one of the most prevalent risk factors as observed in multiple studies, what is the preferred method of blood pressure measurement in hospital and in follow-up? *
  29. What is the frequency of follow up in these young adult patients? *
  30. What steps are taken to ensure adequate follow up in these young adult patients? *
  31. What are the investigations conducted in these patients? *
  32. Do you consider intensive therapy for cardiovascular risk factors? *

  33. Which among the below do you consider intensive therapy for? *

  34. What is your target blood pressure for young adults presenting with MI and HYTN? *

  35. What is your target HbA1c for young adults presenting with MI and Diabetes(T2DM)? *

  36. What is your target LDL for young adults presenting with MI and Dyslipidaemia? *

  37. In your opinion, do you consider the patient compliance of 80% and above to be considered a good indication of overall compliance? *

  38. Adherence defined as patients taking their medication > 80% of the time. Based on this definition, please indicate the percentage (%) of your patients you believe to be compliant when they take medications for statins *

  39. Similarly, please indicate the percentage (%) of your patients you believe to be compliant when they take medications for anti-diabetic drugs *

  40. Also, please mention the percentage (%) of your patients you believe to be compliant when they take medications for anti-hypertensive medications *

  41. Also, please mention the percentage (%) of your patients you believe to be compliant when they take medications for anti- dyslipidaemia medications *

  42. In your opinion, which is the most limiting factor to patients in using the lipid lowering drug therapy ? *

  43. In your practice, what % of Diabetic or hypertensive patients takes statin therapy individually as risk factors? *

  44. According to you what are the reasons for patient’s Discontinuation of statin therapy on their own:- *

  45. What were the major reasons in patients whom you have discontinued statin therapy? *

  46. What is the major underlying cause observed in practice for dyslipidaemia *
  47. What is the major underlying cause observed in practice for hypertension *
  48. What is the major underlying cause observed in practice for diabetes *
  49. What practices have proved effective in counselling the patient for lifestyle changes *
  50. Do all patients receive intensive therapy for management of cardiovascular risk factors? Which patients do you consider intensive therapy for the management of cardiovascular risk factors? *